These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 358473)

  • 21. Proceedings: Effect of microwaves combined with interferon and/or interferon inducers (poly I - poly C) on development of sarcoma 180 in mice.
    Szmigielski S; Luczak M; Bielec JM; Kobus M; Stewart WE; de Clerq E
    J Microw Power; 1976 Jun; 11(2):174-5. PubMed ID: 1047692
    [No Abstract]   [Full Text] [Related]  

  • 22. [The role of interferon therapy in patients with chronic hepatitis].
    Papa MZ; Halperin Z; Bar Meir S
    Harefuah; 1981 Jul; 101(1-2):27-8. PubMed ID: 6172325
    [No Abstract]   [Full Text] [Related]  

  • 23. Phase I-II trials of poly IC stabilized with poly-L-lysine.
    Levine AS; Levy HB
    Cancer Treat Rep; 1978 Nov; 62(11):1907-12. PubMed ID: 728910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infection fighters. Interferon and ribavirin for hepatitis B.
    TreatmentUpdate; 2001; 12(9):2-3. PubMed ID: 12132444
    [No Abstract]   [Full Text] [Related]  

  • 25. Expression of the terminal protein of hepatitis B virus is associated with failure to respond to interferon therapy.
    Foster GR; Goldin RD; Hay A; McGarvey MJ; Stark GR; Thomas HC
    Hepatology; 1993 May; 17(5):757-62. PubMed ID: 7684016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Designing clinical development programs for anti-hepatitis B virus drugs.
    Brown NA
    Methods Mol Med; 2004; 96():499-537. PubMed ID: 14762289
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacokinetic and pharmacological aspects of interferon therapy in man.
    Billiau A
    Acta Microbiol Acad Sci Hung; 1981; 28(3):257-62. PubMed ID: 6171139
    [No Abstract]   [Full Text] [Related]  

  • 28. Interferon: its inducers and some aspects of host resistance in malignancy.
    Merigan TC
    Cancer Chemother Rep; 1974; 58(4):571-8. PubMed ID: 4604626
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prospects for the clinical use of interferon].
    Vopr Virusol; 1978; (6):742-3. PubMed ID: 749355
    [No Abstract]   [Full Text] [Related]  

  • 30. Leukocyte and platelet lowering by some interferon types during viral hepatitis treatment.
    Toccaceli F; Rosati S; Scuderi M; Iacomi F; Picconi R; Laghi V
    Hepatogastroenterology; 1998; 45(23):1748-52. PubMed ID: 9840140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection of newborn mice from a lethal herpes simplex virus infection by human interferon, antibody, and leukocytes.
    Kohl S; Loo LS; Greenberg SB
    J Immunol; 1982 Mar; 128(3):1107-11. PubMed ID: 6173420
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antiviral treatment of chronic hepatitis].
    Müller R
    Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
    [No Abstract]   [Full Text] [Related]  

  • 33. Viral genotypes and response to interferon in patients with acute prolonged hepatitis B virus infection of adulthood in Japan.
    Kobayashi M; Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Suzuki F; Akuta N; Someya T; Matsuda M; Sato J; Takagi K; Miyakawa Y; Kumada H
    J Med Virol; 2002 Dec; 68(4):522-8. PubMed ID: 12376960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing PEG-interferon and ribavirin combination therapy for patients infected with HCV-2 or HCV-3: is the puzzle completed?
    Alberti A
    J Hepatol; 2004 Jun; 40(6):1032-5. PubMed ID: 15158348
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chronic hepatitis treated with alpha-interferon].
    Michael M
    Orv Hetil; 1992 Jul; 133 Suppl 1():63-5. PubMed ID: 1630805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primate animal models and titered inocula for the study of human hepatitis A, hepatitis B, and non-A, non-B hepatitis.
    Tabor E; Purcell RH; Gerety RJ
    J Med Primatol; 1983; 12(6):305-18. PubMed ID: 6094814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proceedings of an international symposium on anti-viral agents in chronic hepatitis B virus infection. London, U.K., 11-12 November 1985.
    J Hepatol; 1986; 3 Suppl 2():S1-317. PubMed ID: 2439567
    [No Abstract]   [Full Text] [Related]  

  • 38. [Chronic viral hepatitis: when interferon does not work].
    Costa C; Rizzetto M
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):127-31. PubMed ID: 7542484
    [No Abstract]   [Full Text] [Related]  

  • 39. [What treatment for chronic viral hepatitis?].
    Dal Monte PR; Giuliani Piccari G
    G Clin Med; 1988; 69(8-9):541-5. PubMed ID: 2462521
    [No Abstract]   [Full Text] [Related]  

  • 40. Apparent cure of hepatitis C virus carrier state after hepatitis B virus superinfection.
    Yoshinaga S; Fukushima S; Masaki N; Hayashi S
    Jpn J Infect Dis; 1999 Oct; 52(5):220. PubMed ID: 10680091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.